SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arizona997 who wrote (118638)9/1/2003 5:24:31 PM
From: vds4   of 150070
 
for africa yes... not for developed world. it could be a big winfall for the company if aid funding is there in africa and the stage 1 test is used for preliminary screening.

but be explicit here. this will never be needed countries with cash. it is very important to get a needle-less test in place in many impoverished areas of the world, but both the stage 1 and stage 2 tests are in fact far less accurate then intravenous testing. unfortunately, supplying needles is simply not an option for certain parts of the world. this is why who has been investigating both this urine test as well as some saliva tests to address the rising needs.

now, it does look indeed that WHO is focusing on cypt's product (i know little about the company, but the product is well known to me) and this in fact could be very big for them. i did buy some and am still holding. but simply putting out messages like that last one is misleading. they have not decided on cypt's product... they simply feel given the fda approvals, that there is enough research in place to evaluate at this point. yes it looks promising, but do not jump to conclusions like that.

martin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News